在癌症中,CSDE1通过通过CSDE1-eIF3a调控复合体调节RPA2来增强基因毒性药物耐药性
Jia-Jia Cui1, Cheng-Xian Guo2, Jun Li3
1Department of Geratic Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, Changsha, Hunan 410008, PR China; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 410008, PR China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha, Hunan 410000, PR China; Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China; Shenzhen Key Laboratory of Chinese Medicine Active substance screening and Translational Research, Shenzhen 518000, PR China.
含有E1 (CSDE1) 的冷震域通过调节DNA修复通路并抑制免疫信号来增强癌细胞对基因毒药物的抵抗力. 作为一个三元复杂的枢纽,CSDE1的作用为改善癌症治疗灵敏度提供了新的策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 基因毒性药物耐药性是癌症治疗的一个主要挑战.
- 含有E1 (CSDE1) 的冷冲击域以前与药物耐药性有关.
研究的目的:
- 证明CSDE1在调节细胞对基因毒药物反应中的作用.
- 阐明CSDE1在调解药物耐药性的机制.
主要方法:
- 对患者样本和癌症细胞系的分析.
- 彗星和免疫光测定用于DNA损伤修复.
- 系统的淘汰赛小鼠模型.
- 生物素拉下,EMSA和co-IP测定用于研究CSDE1-蛋白 (eIF3a) -RNA (RPA2) 相互作用.
主要成果:
- 增加的CSDE1与患者反应不佳和细胞系中药物耐药性增加相关.
- 在CSDE1上调节核酸切除修复 (NER) 和同源重组 (HR) 途径.
- 在小鼠中,CSDE1淘汰会增加DNA损伤,并通过RPA2.2抑制cGAS-STING通路.
- CSDE1 作为一个 CSDE1-eIF3a-RPA2 三元复合体的枢纽.
结论:
- 通过一种新的机制,CSDE1增强了对基因毒药物的耐药性.
- 该研究详细介绍了CSDE1.1的类似拉链的交叉三元结构.
- 研究结果表明,CSDE1调制是改善癌症治疗中基因毒药物敏感性的策略.
更多相关视频
06:59Using Next Generation Sequencing to Identify Mutations Associated with Repair of a CAS9-induced Double Strand Break Near the CD4 Promoter
Published on: March 31, 2022
06:44Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
相关概念视频
DNA Damage can Stall the Cell Cycle
Treatment Resistant Cancers
Inhibition of Cdk Activity
Abnormal Proliferation
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Negative Regulator Molecules
